In a country where millions depend on life-saving medicines, the news of a growing demand for drug discovery services has brought a wave of hope for Indian patients. According to a recent market report, the demand for drug discovery services is expected to rise significantly over the next five years.
This growing demand is attributed to the increasing burden of diseases and the need for innovative treatments in India. The report highlights the potential of drug discovery services in identifying new targets for existing drugs, reducing the time and cost of developing new medicines.
Key Findings of the Report
The report reveals that the drug discovery services market in India is expected to grow at a CAGR of 12% from 2025 to 2030. This growth is driven by the increasing adoption of new technologies and the growing need for personalized medicines.
The report also identifies key process, type, and geographic segments driving the growth of the market. These segments include contract research organizations (CROs), contract manufacturing organizations (CMOs), small molecule drug discovery, biologics, and various regions across India.
Experts believe that the growing demand for drug discovery services will not only improve healthcare outcomes but also create new job opportunities in the sector.
As the demand for drug discovery services continues to grow, patients in India can look forward to better treatment options and improved healthcare outcomes.
However, experts also point out that the growth of the market will depend on various factors, including the availability of skilled manpower and the adoption of new technologies.